Status:
ACTIVE_NOT_RECRUITING
HIDRAdenitis Suppurativa and HEART Disease
Lead Sponsor:
Herlev and Gentofte Hospital
Conditions:
Hidradenitis
Hidradenitis Suppurativa
Eligibility:
All Genders
18+ years
Brief Summary
In a prospective observational cohort study (n = 250) the investigators aim to assess the correlation between cardiac biomarkers, advanced echocardiography and HS severity and determine whether these ...
Detailed Description
Rationale and background CVD is mainly caused by atherosclerosis, now considered as a chronic inflammatory disease of blood vessels . Likewise, HS is a chronic and relapsing, inflammatory, immune medi...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Diagnosis of HS
Exclusion
- Patients unable to cooperate to the study and/or study examinations
- Patients unable to understand and sign informed consent
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2033
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05989945
Start Date
August 1 2023
End Date
August 1 2033
Last Update
August 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen
Hellerup, Copenhagen, Denmark, 2900